Successfully advancing new drugs and life-saving therapies to market for emerging pharma and biotech organizations, involves complex challenges throughout product development. For these companies, choosing the right regulatory pathway can significantly impact the success of bringing innovative therapies to market.

This webinar discusses best practices and key strategies to consider when choosing the best regulatory pathway for new drug application submissions as well as recommends strategies for early-stage biopharma companies to achieve successful outcomes.

• Gain an in-depth understanding of the ANDA and 505(b)(2) process
• Learn successful strategies for advancing your NDA submission
• Understand how to identify and mitigate regulatory risk factors in your go-to-market strategy
• Understand the importance of developing a regulatory strategy

• Presenter

Sharon Ayd

MA

Vice President & Principal, Advarra Consulting